Key Takeaways
- Distribution drove the quarter: The chemical distribution segment outperformed manufacturing, with revenue of ~₹55.8 crore and healthy EBITDA growth on higher volumes and better realizations for products like Resorcinol and Meta Cresol.
- Exports halved on logistics snarls: Export share fell to 21% from 45% YoY as shipping issues and high freight costs caused Acrylamide liquid order rollovers, though management sees vessel availability improving in the current quarter.
- A new specialty chemical plant is taking shape: An EC application is progressing for a project with a Japanese principal, a 20-acre land parcel has been identified, and CapEx is pegged at ₹20–30 crores, but product details remain under wraps due to secrecy agreements.
- Balance sheet is clean and lean: The company is 100% long-term debt free with rationalized inventories and sufficient reserves, funding growth from internal accruals.
- What to watch next quarter: Whether the promised export volume recovery in Acrylamide liquid materializes, the uptake of new ceramic binder versions in a subdued Morbi market, and any further disclosure on the specialty chemical project timeline.
Segment Performance
- Distribution segment led growth: Revenue reached close to ₹55.8 crore with healthy EBITDA expansion, driven by higher sales volumes and better realizations for key products including Resorcinol, Isophthalic acid, and Meta Cresol.
- Manufacturing faced logistics headwinds: The stock-and-sale model helped manage distribution efficiently, but export business in Acrylamide liquid witnessed order rollovers due to shipping issues and high freight costs impacting certain markets.
- Acrylamide powder gained local traction: Sales increased in the domestic market with the addition of new customers; the company remains the only Acrylamide powder manufacturer in the world outside China.
- NMA business is picking up: The company captured a major part of demand from key customers and principal users in India, with efforts underway to increase export volumes.
- Ceramic binder market stayed subdued: The Morbi market was hit by higher gas prices and increased freight rates hampering tile manufacturers' exports, though usual sales volumes for ceramic binder were achieved during the quarter.
- Acrylamide realizations improved despite flat input costs: Raw material prices remained stable at $1,200–$1,300 per ton, but good market reach and marketing efforts improved net realization for Acrylamide.
Export & Logistics
- Export contribution collapsed YoY: Exports contributed 21% of revenue versus 45% in the corresponding quarter, primarily due to Acrylamide liquid order rollovers and shipping disruptions.
- US oil and gas business provided stability: Steady business from the US oil and gas sector supported export volumes in the distribution segment, with efforts to expand the product portfolio in both export and domestic markets.
- Vessel availability is improving: Management noted that the international logistics situation is improving slightly in terms of vessel availability, which should help achieve much higher export volumes for Acrylamide liquid in the ongoing quarter.
- NMA exports are a focus area: With a majority share of business already secured from key customers in India, the company is now working to increase NMA export volumes and expects substantial sales growth during the current quarter.
New Projects & CapEx
- Specialty chemical plant with a Japanese principal: An EC application for the new chemicals project is moving forward smoothly, with the collaboration structured around a Japanese principal.
- 20-acre land bank being created: A new 20-acre land parcel has been identified and earmarked for future projects, though the acquisition is yet to be finalized.
- CapEx guided at ₹20–30 crores: The specialty chemical project will carry a product mix, with revenue and other metrics dependent on the final mix, which remains undisclosed.
- Polyacrylamide solid R&D nearing completion: The R&D process is fully expected to be completed by the end of this fiscal year, after which plant setup will begin; the plant building is already ready.
- New R&D facility under development: The company is enhancing its R&D team to focus on new product development, with a dedicated facility currently being built.
Daga: "All I can say right now is that, it's a specialty chemical plant that we are setting up because of secrecy agreements, we cannot divulge too many details on the product classification, etc. at this point of time."
Raw Material & Margin Dynamics
- Acrylonitrile raw material prices weakened: Raw material prices have softened during the current quarter, which management expects will help maintain good margins and profitability for Acrylamide liquid and solid.
- Reliance acrylonitrile restart is not a material factor: Reliance started production of acrylonitrile in its earlier unit from June onwards, but management characterized it as a very small capacity and not a significant source for raw material booking.
- Distribution margins benefited from product mix: Better realizations on products like Resorcinol, Isophthalic acid, and Meta Cresol helped ramp up margins in the distribution segment.
- Acrylamide-to-Polyacrylamide conversion ratio is application-dependent: When pressed by an analyst, management declined to give an exact conversion percentage, stating it ranges from 10–15% to 25% depending on the application and product mix.
Product Pipeline & Market Development
- New ceramic binder versions incoming: With overall binder demand subdued due to higher gas prices and a dip in export volumes, the company is ready to introduce newer, more robust versions of the binder during the current quarter to drive better acceptance and higher volumes.
- Polyacrylate dispersant under trial: The product is undergoing trials at various plants, which management expects will further augment sales for this segment.
- Distribution segment adding customers: The company is expanding its product portfolio in both export and domestic markets and adding new customers, with the impact already reflecting in better performance during the ongoing quarter.
- Strong principal relationships support allocation: Good allocation from principals is helping the company cater to higher demand in the domestic market, expected to bring additional sales volume and increase profitability substantially during the ongoing quarter.
People & Organization
- Talent acquisition is a stated priority: Management is putting significant effort into acquiring a good talent pool, calling it one of the most important resources for the organization as it looks to accelerate growth.
- R&D team being strengthened: The company is enhancing its R&D team in parallel with the development of the new R&D facility, focusing on new product development.
- Growth acceleration is the broader mandate: Beyond specific projects, management is looking to expand further and accelerate growth during the course of this year by strengthening the internal team.
Daga: "We are putting a lot of effort in acquiring and you know having a good talent pool because that we believe is one of the, you know, most important resources for an organization."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Polyacrylamide solid R&D completion | R&D process fully completed, plant setup to begin thereafter | End of FY25 |
| Specialty chemical CapEx | ₹20 crores to ₹30 crores | Undisclosed (EC application in progress) |
| Acrylamide liquid export volume recovery | Much higher export volume on improving vessel availability | Ongoing quarter (Q2 FY25) |
| New ceramic binder introduction | Newer, more robust binder versions to drive higher volumes | During the current quarter |
| NMA sales growth | Substantial growth expected | During the current quarter |
| Distribution segment profitability | Additional sales volume and substantial margin increase | Ongoing quarter |
Key Metrics
| Metric | Q1 FY25 |
|---|---|
| Revenue growth | ~8% YoY |
| EBITDA growth | 17% YoY in absolute terms |
| Chemical distribution revenue | ₹55.8 cr |
| Export revenue share | ~21%, compared to 45% in Q1 FY24 |
| Legacy businesses revenue share | ~1% |
| Acrylamide liquid installed capacity | 32,000 MT per annum; 20,000 MT for merchant sales, balance captive |
| Polyacrylamide liquid capacity | 40,000 MT per annum |
| Acrylamide solid installed capacity | 3,600 MT per annum |
| N-methylol Acrylamide capacity | 2,000 MT per annum |
| Key raw material (acrylonitrile) price range | $1,200–$1,300 per ton during the quarter |
| Debtor days target | 60 days |
| Expected CapEx for new specialty chemical project | ₹20 cr to ₹30 cr |